Stryker will invest about $400 million in CMR Surgical for preferred equity, an exclusive option to acquire the company, and exclusive U.S. sales rights for the Versius surgical robot. The deal expands Stryker into soft-tissue robotics.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
